Immuron Limited
IMRN · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $7,287 | $4,903 | $1,805 | $765 |
| % Growth | 48.6% | 171.7% | 135.8% | – |
| Cost of Goods Sold | $2,522 | $1,566 | $65 | $242 |
| Gross Profit | $4,765 | $3,337 | $1,740 | $524 |
| % Margin | 65.4% | 68.1% | 96.4% | 68.4% |
| R&D Expenses | $3,597 | $5,375 | $2,592 | $658 |
| G&A Expenses | $4,484 | $4,556 | $4,221 | $3,524 |
| SG&A Expenses | $7,936 | $6,585 | $5,148 | $3,941 |
| Sales & Mktg Exp. | $3,452 | $2,030 | $927 | $417 |
| Other Operating Expenses | -$1,424 | -$2,823 | -$2,432 | -$1,205 |
| Operating Expenses | $10,110 | $9,138 | $5,309 | $3,393 |
| Operating Income | -$5,345 | -$5,801 | -$3,569 | -$2,870 |
| % Margin | -73.3% | -118.3% | -197.8% | -375% |
| Other Income/Exp. Net | $129 | -$1,136 | -$218 | $16 |
| Pre-Tax Income | -$5,216 | -$6,937 | -$3,787 | -$2,854 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5,216 | -$6,937 | -$3,787 | -$2,854 |
| % Margin | -71.6% | -141.5% | -209.8% | -373% |
| EPS | -0.9 | -1.22 | -0.66 | -0.5 |
| % Growth | 26.2% | -84.8% | -32% | – |
| EPS Diluted | -0.9 | -1.22 | -0.66 | -0.5 |
| Weighted Avg Shares Out | 5,773 | 5,697 | 5,695 | 5,689 |
| Weighted Avg Shares Out Dil | 5,773 | 5,697 | 5,695 | 5,689 |
| Supplemental Information | – | – | – | – |
| Interest Income | $136 | $328 | $116 | $22 |
| Interest Expense | $7 | $8 | $10 | $6 |
| Depreciation & Amortization | $50 | $46 | $49 | $27 |
| EBITDA | -$5,307 | -$5,170 | -$3,360 | -$3,091 |
| % Margin | -72.8% | -105.4% | -186.2% | -403.9% |